Journal of Cancer Therapy and Research is happy to announce the Special Issue on the very interesting topic on Breast Cancers: a challenge in women’s global health
Aims and Scope of the Special Issue: Breast cancer is the most frequent malignancy in women worldwide and is curable in ~70–80% of patients with early-stage, non-metastatic disease. Advanced breast cancer with distant organ metastases is considered incurable with currently available therapies. On the molecular level, breast cancer is a heterogeneous disease; molecular features include activation of human epidermal growth factor receptor 2 (HER2, encoded by ERBB2), activation of hormone receptors (oestrogen receptor and progesterone receptor) and/or BRCA mutations. Treatment strategies differ according to molecular subtype.
Management of breast cancer is multidisciplinary; it includes loco-regional (surgery and radiation therapy) and systemic therapy approaches. Systemic therapies include endocrine therapy or hormone receptor-positive disease, chemotherapy, anti-HER2 therapy for HER2-positive disease, bone stabilizing agents, poly (ADP-ribose) polymerase inhibitors for BRCA mutation carriers and, quite recently, immunotherapy. Future therapeutic concepts in breast cancer aim at individualization of therapy as well as at treatment de-escalation and escalation based on tumor biology and early therapy response. Next to further treatment innovations, equal worldwide access to therapeutic advances remains the global challenge in breast cancer care for the future. This special issue is devoted to articles on detection, diagnosis, prevention, and treatment of breast cancer.
Keywords reflecting the themes of the special issue:
1. Breast Cancer: Targets and Therapy
2. Metastatic Breast Cancer
3. Breast-Cancer Screening
4. Breast Cancer Metastasis
5. Breast Cancer Cells
6. Breast Cancer Chemotherapy
7. Breast Ultrasonography
8. Breast Cyst
Guest Editor: Divya Jain
Guest Lead Editor: Dr. Godfrey
Editorial Office is Accepting Special Issue Submissions; you are cordially invited to submit Review, Short Commentary, and Letter to Editor, opinion, communication, perspective, Research and Review (or any type of article) via an e-mail: firstname.lastname@example.org